Viral Hepatitis

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will provide the nonhepatologist with the basics on how to manage HCV infection in persons with liver-related complications. This presentation will also provide (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity as part of a nationwide continuing medical education (CME) effort for physicians on the evolving challenges of managing HCV infection. This webinar highlights key data presented at EASL 2017, the International Liver Congress in Amsterdam, Netherlands, held from April 19 to April 23. The most (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. The current armamentarium of direct-acting antiviral (DAA) treatments for hepatitis C virus (HCV) infection is vast. Among currently available treatments are 1-pill coformulations; US Food (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. The potential for drug-drug interactions is an important consideration in the treatment of hepatitis C virus (HCV) infection in HIV/HCV-coinfected individuals. Regimens for HCV infection (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. Learning Objectives At the conclusion of this webinar, learners will be able to: Discuss the treatment of HCV in patients with decompensated cirrhosis Registration Who (more…)

Overview Assessment of Needs This webinar will briefly review the potential for the emergence of HCV drug resistance following DAA treatment failure. Dr Wyles will provide historical context for the impact of HCV DAA resistance on retreatment approaches with older DAA regimens. He will also review data supporting the approval of new DAA regimens, focusing (more…)

Overview Assessment of Needs Safe, highly effective, curative direct-acting antiviral (DAA) therapies can eliminate hepatitis C virus (HCV) from the host. This therapeutic revolution raises the prospect of control of the HCV epidemic on a population level. Traditionally, interferon alfa–based therapies were withheld from people who inject drugs because of concerns about precipitating drug use (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. Learning Objectives Upon completion of this webinar, learners will be able to: Use current diagnostic techniques to reliably diagnose cirrhosis in patients with chronic liver (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing liver complications in HIV-infected individuals as part of a nationwide continuing medical education (CME) effort for physicians. Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease in the United States and is very common in HIV-infected (more…)

Overview Assessment of Needs The IAS–USA offers this state-of-the-art activity on the evolving challenges of managing HCV disease as part of a nationwide continuing medical education (CME) effort for physicians. This webinar will utilize patient case scenarios to lead both novice and experienced practitioners through the diagnosis, workup, and recommended treatment of HCV. The most (more…)